IDENTIFICATION OF THERAPEUTIC STRATEGIES DIRECTED TO ACUTE MYELOID LEUKEMIA MINIMAL RESIDUAL DISEASE

被引：0
|
作者：
van Gils, N. [1 ]
Kessler, F. L. [1 ]
Broux, M. [2 ,3 ]
Denkers, F. [1 ]
Rutten, A. [1 ]
Demeyer, S. [2 ,3 ]
Cools, J. [2 ,3 ]
de Leeuw, D. C. [1 ]
Janssen, J. J. W. M. [1 ]
Smit, L. [1 ]
机构：
[1] Amsterdam UMC, Dept Hematol, Locat VUmc, Amsterdam, Netherlands
[2] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium
[3] VIB Ctr Canc Biol, Leuven, Belgium
来源：
ANNALS OF HEMATOLOGY | 2023年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
60
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] Minimal residual disease-directed therapy in acute myeloid leukemia
    Kayser, Sabine
    Schlenk, Richard F.
    Grimwade, David
    Yosuico, Victor E. D.
    Walter, Roland B.
    BLOOD, 2015, 125 (15) : 2331 - 2335
  • [2] Development of minimal residual disease-directed therapy in acute myeloid leukemia
    Freeman, Sylvie D.
    Jovanovic, Jelena V.
    Grimwade, David
    SEMINARS IN ONCOLOGY, 2008, 35 (04) : 388 - 400
  • [3] Minimal Residual Disease in Acute Myeloid Leukemia
    Gomez-Arteaga, Alexandra
    Guzman, Monica L.
    BIOLOGICAL MECHANISMS OF MINIMAL RESIDUAL DISEASE AND SYSTEMIC CANCER, 2018, 1100 : 111 - 125
  • [4] Minimal Residual Disease in Acute Myeloid Leukemia
    Jeyakumar, Deepa
    O'Brien, Susan
    JAMA ONCOLOGY, 2020, 6 (12) : 1899 - 1900
  • [5] Minimal Residual Disease in Acute Myeloid Leukemia
    Sung, Pamela J.
    Luger, Selina M.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (01)
  • [6] Minimal Residual Disease in Acute Myeloid Leukemia
    Pamela J. Sung
    Selina M. Luger
    Current Treatment Options in Oncology, 2017, 18
  • [7] Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
    Buccisano, Francesco
    Maurillo, Luca
    Del Principe, Maria Ilaria
    Del Poeta, Giovanni
    Sconocchia, Giuseppe
    Lo-Coco, Francesco
    Arcese, William
    Amadori, Sergio
    Venditti, Adriano
    BLOOD, 2012, 119 (02) : 332 - 341
  • [8] Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemia
    Pettit, Kristen
    Stock, Wendy
    Walter, Roland B.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1527 - 1533
  • [9] Minimal Residual Disease Quantitation in Acute Myeloid Leukemia
    Shook, David
    Coustan-Smith, Elaine
    Ribeiro, Raul C.
    Rubnitz, Jeffrey E.
    Campana, Dario
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S281 - S285
  • [10] Molecular Minimal Residual Disease in Acute Myeloid Leukemia
    Jongen-Lavrencic, M.
    Grob, T.
    Hanekamp, D.
    Kavelaars, F. G.
    al Hinai, A.
    Zeilemaker, A.
    Erpelinck-Verschueren, C. A. J.
    Gradowska, P. L.
    Meijer, R.
    Cloos, J.
    Biemond, B. J.
    Graux, C.
    Kooy, M. van Marwijk
    Manz, M. G.
    Pabst, T.
    Passweg, J. R.
    Havelange, V.
    Ossenkoppele, G. J.
    Sanders, M. A.
    Schuurhuis, G. J.
    Lowenberg, B.
    Valk, P. J. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1189 - 1199
12345